Table 3 Predictive value of FACED score on number and severity of future exacerbations and hospitalizations in the Latin America cohort
From: Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts
AUC-ROC (FACED) | Best cut-off points (sensitivity/specificity) | |
|---|---|---|
At least 1 exacerbation/year (n = 228; 35.0%) | 0.70 (0.67–0.75) | NA |
At least 2 exacerbation/year (n = 117; 17.9%) | 0.72 (0.68–0.78) | NA |
At least 1 hospitalization/year (n = 56; 8.6%) | 0.82 (0.78–0.87) | >3.5 points (Sensitivity: 79% and Specificity: 78%) |
At least 2 exacerbation or 1 hospitalization/year (n = 150; 23.0%) | 0.78 (0.74–0.82) | >2.5 points (Sensitivity: 82% and Specificity: 70%) |